(Q74094348)
Statements
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumors (English)
P J Creaven
L Pendyala
N J Meropol
N J Clendeninn
E Y Wu
G M Loewen
A Proefrock
A Johnston